NCT06389682View on ClinicalTrials.gov

Pharmacokinetics, Biodistribution, Radiation Dose and Safety Study of 68Ga-NYM005 in Patients

PHASE1/PHASE2CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

June 17, 2024

Primary Completion Date

January 8, 2025

Study Completion Date

January 8, 2025

Conditions

Clear Cell Renal Cell Carcinoma Metastatic

Interventions

DRUG

68Ga-NYM005 injection

he radiation dose is about 2-7 mCi for a single patient.Using a syringe to withdraw 68Ga-NYM005 injection, the dose will be administered via an intravenous injection and the injection time will be about 45-60 seconds.

Trial Locations (2)

214000

Affliated Hospital of Jiangnan University, Wuxi

Unknown

Peking Union Medical College Hospital, Beijing

All Listed Sponsors

lead

Norroy Bioscience Co., LTD

INDUSTRY

NCT06389682 - Pharmacokinetics, Biodistribution, Radiation Dose and Safety Study of 68Ga-NYM005 in Patients | Biotech Hunter | Biotech Hunter